SISAQOL Trademark

Serial Number: 99560444

SISAQOL is a trademark filed by ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER, in short EORTC on December 22, 2025. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

41

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

44

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER, in short EORTC

Avenue E. Mounier 83/11
Brussels B-1200 , BE

Entity Type: 99

Legal Representation

Attorney of Record

Martin W. Schiffmiller

2,770 trademarks filed View all →

Correspondence Address

Martin W. Schiffmiller Kirschstein Israel Schiffmiller & Pieroni, P.C.

66 Palmer Avenue, Suite 49B

Bronxville, NY 10708

United States

Trademark Details

Filing Date

December 22, 2025

Registration Date

Not Registered

Goods & Services

Medical consultancy and advisory services related to patient-reported outcomes (PROs), including their use in clinical practice and treatment evaluation; Providing medical information related to PROs; Provision of medical information and guidance to healthcare professionals on interpreting and applying patient-reported outcomes (PROs) data in oncology and other therapeutic areas; Medical consultancy in the field of patient-centered care and medical outcomes assessment; provision of medical consultancy to support personalized treatment planning through the structured use of patient-reported outcomes (PROs) frameworks

Scientific and technological services, namely the development and validation of methodologies for the design, analysis, interpretation, and presentation of patient-reported outcomes (PROs) in clinical trials or other research; Research and design of standardized data analysis frameworks in oncology and other therapeutic areas; Provision of scientific information, clinical research support and related consulting services; Development of software tools for the implementation of patient-reported outcomes (PROs) in health-related research; hosting and maintenance of online platforms and non-downloadable software for patient-reported outcomes (PROs) methodology implementation

Arranging of conferences, workshops and training sessions relating to education in the field of patient-reported outcomes (PROs) and health-related quality of life (HRQoL); Provision of non-downloadable electronic publications all in the field of patient-reported outcomes (PROs) and health-related quality of life (HRQoL); Provision of training and recommendations relating to the reporting of outcomes in clinical research and healthcare practice